Efficacy and Safety of CKD-828 to Stage 2 Hypertension
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The aim of present study is to evaluate the efficacy and safety of two dose combination of
S-Amlodipine/Telmisartan (2.5/40mg, 2.5/80mg and 5/80mg) compared with S-Amlodipine
monotherapy (2.5mg and 5mg) in patients with Stage 2 hypertension.